To further examine whether AHR activation is sufficient to promote HIV-1 infection, PHA-P-activated primary CD4+ T cells were first infected with HIV-luc/NL4-3 for 6 h and then further treated with FICZ for an additional 4 days. The gene discussed is AHR; the disease is HIV-1 infection.